Bioeast Biotech
PrivateLast Round
Series A
Extension
May 10, 2022
Total Funding Raised
$37.8M
Company Overview
Bioeast Biotech operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series A Extension round in May 2022.
Bioeast Biotech is a biotechnology company that provides core raw materials and overall solutions for the in-vitro diagnostic, life science, and biomedical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioeast Biotech Comparables
Compare Bioeast Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou VDO Biotech Co., Ltd. | 83% | |
| Medix Biochemica | 81% | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 77% |
For institutional investors. Book with your work email.
Bioeast Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 10, 2022 | ||||
| Series A | Sep 1, 2021 |
For institutional investors. Book with your work email.
Bioeast Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Series A, Angel |
| YuanBio Venture Capital | Series A, Angel |
| LYFE Capital | Series A Extension |
| Grand Mount Capital | Series A |
| 华创资本 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2024
Grew 20% QoQ from 15 to 18 employees.
- Oct 23, 2024
Grew 20% QoQ, from 15 to 18 employees.
For institutional investors. Book with your work email.
Bioeast Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioeast Biotech's valuation, stock price, and market status.
Is Bioeast Biotech a public or private company?
Bioeast Biotech is a private company.
What is the current stock price of Bioeast Biotech?
Bioeast Biotech is a private company, so its shares have no public market price. Caplight tracks Bioeast Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioeast Biotech worth (valuation)?
Valuation information for Bioeast Biotech is not publicly available.
Can I buy Bioeast Biotech stock?
Bioeast Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioeast Biotech's last funding round?
Bioeast Biotech's most recent funding round was Series A Extension on May 10, 2022.
Who are the main investors in Bioeast Biotech?
Key investors in Bioeast Biotech include LYFE Capital, 华创资本.
Will Bioeast Biotech IPO soon?
No public IPO plans have been announced for Bioeast Biotech.
How can I track Bioeast Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Bioeast Biotech's shares on secondary markets.